Rights and permissions
About this article
Cite this article
Groundbreaking benefits with azacitidine in higher-risk MDS. Inpharma Wkly. 1641, 12 (2008). https://doi.org/10.2165/00128413-200816410-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816410-00024